Previous efforts to identify mechanisms of resistance to CDK4/6 inhibition have found that lack of Rb protein, increased cyclin E expression, IL6/STAT3 pathway activation and decreased DNA repair are some of the underlying mechanisms of resistance in ER+ breast cancer cells [6,13,19,27,28]. The gene discussed is IL6; the disease is breast carcinoma.